The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmaMATCH) Trial: a multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010)
Authors
Kernaghan, SMoretti, L
Kilburn, L
Wilkinson, K
Snowdon, C
Morden, J
Macpherson, I
Wardley, Andrew M
Roylance, R
Baird, R
Ring, A
Turner, N
Bliss, JM
Affiliation
Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), United KingdomIssue Date
2019